Cite Filings / FULC / 0000935836-26-000331

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. Filed 2026-06-25 Acc 0000935836-26-000331

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-07-17 SCHEDULE 13G Statement of Beneficial Ownership
2026-07-02 4 Options or other derivatives
2026-06-30 4 Director sold 18,000 shares at $3.65 ($65,614)
2026-06-26 144 Sale of Securities
2026-06-25 8-K Shareholder vote results
2026-06-25 SCHEDULE 13G Statement of Beneficial Ownership
2026-06-25 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…